Is European legislation killing allergy diagnostics?

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 5, 2012, Pages 475-476

  Zuberbier, Torsten ^a   Werfel, Thomas ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN;

CHRONIC RESPIRATORY TRACT DISEASE; EDITORIAL; EUROPE; HEALTH; HUMAN; LAW; MEDICAL LITERATURE; MEDICAL RESEARCH; PATCH TEST; PRICK TEST; PRIORITY JOURNAL; SKIN ALLERGY; SKIN TEST;

ALLERGENS; DERMATITIS, ALLERGIC CONTACT; EUROPE; EUROPEAN UNION; HUMANS; LEGISLATION AS TOPIC; SKIN TESTS;

EID: 84865978107     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32835801b0     Document Type: Editorial

References (4)

1. Samoliński B, Fronczak A, Kuna P, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67:726-731.
2. Heinzerling LM, Burbach GJ, Edenharter G, et al. GA2LEN skin test study I: GA2LEN harmonization of skin prick testing: novel sensitization patterns for inhalant allergens in Europe. Allergy 2009; 64:1498-1506.
3. Burbach GJ, Heinzerling L, Edenharter G, et al. GA2LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy 2009; 64:1507-1515.
4. Bousquet PJ, Burbach G, Heinzerling LM, et al. GA2LEN skin test study III: minimum battery of test inhalent allergens needed in epidemiological studies in patients. Allergy 2009; 64:1656-1662.